Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Dr. Forouzandeh Fereidooni Curriculum Vitae Anatomical and Clinical Pathologist Associate Professor of Pathology, Director of Tumor Cell Bank of Iran , Cancer Institute, Tehran University of Medical Sciences Director of Surgical Pathology, Shahriar General Hospital The Cancer Institute of Iran Imam Khomeini Hospitals Complex, Keshavarz Blvd, Tehran, Iran Telephone:+98-21- 6112504 Fax: +98-21-6428655 E-Mail: [email protected] Printed 14/02/2009 Dr. Forouzandeh Fereidooni ACADEMIC POSITIONS 2004 – Present Founder/Director of Tumor Cell Bank Iran Cancer Institute, Tehran, Iran www.irantumorbank.com 1984 - Present Associate Professor of Pathology Iran Cancer Institute, Tehran University of medical Sciences, Tehran, Iran http://medicine.tums.ac.ir/en/Professor_cv.aspx?lt=8&UID=379 1984-Present Director/Pathologist, Department of Cytology & Pathology Shahriar General Hospital, Tehran, Iran 1994-1995 Assistant Professor of Pathology Faculty of Medicine, Azad University, Tehran, Iran APPOINTMENTS 1999, Trustee of Medical Council of Iran 1995-2005, Member of National Residency Evaluation Exam Committee for Pathology Dr. Forouzandeh Fereidooni TRAININGS Electron Microscopy Training (specimen preparation, TEM, ultrastructural diagnosis) St. Michael's Hospital, University of Toronto , Toronto, Canada, 2001 Hospital for Sick Children , University of Toronto, Toronto , Canada, 2000 Internship and Residency Training Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran, 1983 Medical School MD: Shahid Beheshti (Melli) University, School of Medicine, Tehran, Iran, 1976 CERTIFICATION Board Certification: The Iranian Board of Pathology (Anatomic and Clinical Pathology), 1983 PARTICIPATION IN INTERNATIONAL MEETINGS 1. 3rd Regional Conference of Asian Pacific Organization for Cancer Prevention (APOCP), GI cancer control, 2005, Rasht, Iran 2. 2nd International Congress on Advances in Hematology – Oncology and BMT, 2001, Tehran, Iran 3. Pathology Update, 1999, Faculty of Medicine, University of Toronto, Ontario, Canada 4. Advanced Biotechnology and Clinical Diagnosis Symposium, 1999, Ontario, Canada 5. 1st International Symposium on the Molecular Pathology and Clinical Aspects of Inflamed Liver: alcohol and cytokines, 1998, Ontario, Canada 6. MGH Lung Diseases Seminar,1997, Tehran, Iran 7. XIII World Congress of s & Obstetrics (FIGO), 1991, Singapore 8. UICC15th International Congress, 1990, Hamburg, Germany Dr. Forouzandeh Fereidooni MEMBERSHIP • Breast Cancer Society of Canada • Cancer Research Center, Cancer Institute of Iran • International Society for Biological and Environmental Repositories (ISBER) • Iranian Association of Pathologists (IAP) • Medical Council of Iran Dr. Forouzandeh Fereidooni PUBLICATIONS 1. Mostakhdemin Hoseini Z. Kamali F. Fereidooni F. (corresponding author) “Tumor Bank” Journal of Clinical and Anatomical Pathology, 2008 Vol 28 No(16):34-35 2. Daryai P. Tayari N. Ghaderi Sohi S. Fereidooni F. (corresponding author) “Primary small cell carcinoma of the esophagus coexisting with squamous cell carcinoma: a case report” Bulletim of the Cancer Institute of Iran, 2006 Autumn Vol:1 No(3):55-60 3. Fereidooni F, Nasiri M. "Clinicopathological and Immunohistochemical Patterns in Castleman Disease: Report of 15 Cases." (In revision) 4. Fereidooni F, Kovacs K, Azizi MR, Nikoo M. "Skin metastasis from an occult esophageal adenocarcinoma." Can J Gastroenterol 2005 Nov;19(11):673-6 5. Fereidooni F, Fornasier VL. "Soft tissue sarcoma, pathological demonstration of vascularization." Acta Medica-Iranica 2005, 43:135-143 6. Fereidooni F, Horvath E, Kovacs K. "Humoral hypercalcemia of malignancy due to bipartite squamous cell/small cell carcinoma of the esophagus immunoreactive for parathyroid hormone realted protein." Dis Esophagus 2003, 16:335-338 7. Gaffey TA, Scheithauer BW, Lloyd RV, Burger PC, Robbins P, Fereidooni F, Horvath E, Kovacs K, Kuroki T, Young WF jr, Sebo TJ, Riehle DL, Belzberg AJ. "Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases." J Neurosurg 2002, 96:352-360 8. Scheithaver BW, Fereidooni F, Horvath E, Kovacs K, Robbins P, Tews D, Henry K, Pernicone P, Gaffrey TA Jr, Meyer FB, Young WF, Fahlusch R, Buchfelder M, Lloyd RV. "Pituitary carcinoma: an ultrastructural study of eleven cases.” Ultrastructural Pathol 2001, 25:227-242 9. Kovacs K, Rotondo F, Stefaneanu L, Fereidooni F, Horvath E, Lioyd RV, Scheithaver BW. "Glucocorticoid receptor expression in nontumorous human pituitaries and pituitary adenomas." Endocrinopathology 2000, 11:267-275 10. Fereidooni F, Valizadeh U. "Study of 20 cases of Castleman Disease in Iran and review of the literature." Irn J Med Sci 1994, 19:112-119 11. Shams R, Fereidooni F. "Breast masses in adolescent patients in Iran." Acta Medica-Iranica 1987, 29:61-67 Dr. Forouzandeh Fereidooni FIELDS OF RESEARCH 1. Breast Cancer Photodynamic Therapy Present research Cancer Institute, Tehran University, Tehran, Iran In collaboration with Dr. Khashayar Ghandi from Mount Allison University (Canada) 2. Sentinel Lymph Node importance in Breast Cancer staging (Tc-Sb2S2) Present research Cancer Institute, Tehran University , Tehran, Iran 3. Evaluation of Immunohistochemical Patterns in order to predict Castleman's Disease prognosis Present research Cancer Institute, Tehran University, Tehran, Iran 4. Inflamed Esophageal Tissue, Presence of P53 and the Probability of neoplastic changes 2002-04 Iran genetics Engineering society, Tehran, Iran 5. Effect of shark’s chondroid extracts on rabbit’s induced Osteosarcoma 2001 Cancer Institute, Tehran University, Tehran, Iran 6. Soft tissue tumors, evaluation of Pathologic vascularization 1999-2000 Wellesley hospital, Toronto University, Toronto, Canada In collaboration with Victor L. Fornasier, MD, FRCP(C), Director/Pathologist in Chief, Department of Pathology & Cytology, Wellesley Hospital 7. Glucocorticoid receptor expression in nontumorous pituitaries and pituitary adenomas 1999-2000 St. Michael’s Hospital, Toronto University, Toronto, Canada In collaboration with Kalman Kovacs, MD, FRCP(C), Department of Pathology of St. Michael's Hospital Dr. Forouzandeh Fereidooni PRESENTATIONS 1. Tumor bank presentation and work shop Iranian Cancer Institute, 2009, Tehran, Iran 2. The necessity of tumor bank 10th annual congress of pathologists, 2009, Tehran, Iran 3. Immature teratoma in pregnancy Association of gynecology and oncology, 2008, Tehran, Iran 4. Gastric tumors, pathology, tumor markers & staging 33rd congress of surgeons, 2008, Tehran, Iran 5. Early breast cancer 32nd congress of surgeons society, 2008, Tehran, Iran 6. Pathology of thyroidal tumors 32nd congress of surgeons society, 2008, Tehran, Iran 7. Skin metastasis of esophagogastric adenocarcioma Imam Hospital grand round, 2008, Tehran, Iran 8. Melanocytic disorders 9th annual congress of pathology, 2008, Tehran, Iran 9. Biobank Prevention and early detection of cancer congress, 2008, 10. Thyroidal differentiated tumors 18th annual congress of Cancer Institute, 2007, Tehran, Iran 11. Ovarian pathology Iranian scientific society of pathologists, 2007, Tehran, Iran 12. Pathology of vulva and vagina Iranian scientific society of pathologists, 2007, Tehran, Iran 13. Breast cancer, conservative therapy or mastectomy? Breast congress, 2006, Tehran, Iran 14. Allergy Iranian Association of Pathologists (IAP), 23rd Scientific Sessions, 2006, Tehran, Iran 15. Organ Transplantation Iranian Association of Pathologists (IAP), 23rd Scientific Sessions, 2006, Tehran, Iran 16. Ovarian tumors The 30th Annual Iranian Association of Surgeons Congress (IASC), 2006, Tehran, Iran 17. Axillary masses The 30th Annual Iranian Association of Surgeons Congress (IASC), 2006, Tehran, Iran Continued... Dr. Forouzandeh Fereidooni PRESENTATIONS 18. WHO, Soft tissue Classification The 18th Annual Conference of Iran Cancer Institute, 2006, Tehran, Iran 19. Breast Cancer in Young Women The 29th Annual Iranian Association of Surgeons Congress (IASC), 2005, Tehran, Iran 20. Advanced Breast Cancer The 29th annual Iranian Association of Surgeons Congress (IASC), 2005, Tehran, Iran 21. Colorectal Carcinoma The 17th Annual Conference of Iran Cancer Institute, 2005, Tehran, Iran 22. Skin Metastasis of GI Cancers (Poster presentation) The 17th Annual Conference of Iran Cancer Institute, 2005, Tehran, Iran 23. Cancer Institute Tumor Cell Banking Iranian Association of Pathologists (IAP), 22nd Scientific Sessions, 2005, Tehran, Iran 24. Difficulties in Molecular Pathology (Tumor Cell Banking) Iranian Association of Pathologists (IAP), 22nd Scientific Sessions, 2005, Tehran 25. Bladder Preservation The 28th Annual Iranian Association of Surgeons Congress (IASC), 2004, Tehran, Iran 26. Arthritis and Arthrosis Iranian Association of Pathologists (IAP) – Lecture for General Practitioners, 2004, Tehran 27. Cirrhosis Clinical – Anatomical Pathology Congress, 2002, Tehran, Iran 28. Arthritis Iranian Association of Pathologists (IAP) – Lecture for General Practitioners, 2001, Tehran 29. Rheumatic Heart Disease Iranian Association of Pathologists (IAP), 18th Scientific Sessions, 2001, Tehran, Iran 30. Advanced Breast Cancer The 24th Annual Iranian Association of Surgeons Congress (IASC), 2001, Tehran, Iran Continued... Dr. Forouzandeh Fereidooni 31. Rheumatoid Heart Disease Iranian Association of Pathologists (IAP), 18th Scientific Sessions, 2001, Tehran, Iran 32. Management of Advanced Breast Cancer Annual Meeting of the Iranian Radiation Oncologist Society, 2001, Tehran, Iran 33. Rheumatoid Heart Disease Iranian Association of Pathologists (IAP), 17th Scientific Sessions, 2000, Tehran, Iran 34. Pituitary Tumors The 11th Annual Conference of Iran Cancer Institute – Endocrine tumors, 1999, Tehran, Iran 35. Cytopathology in Breast Carcinoma The 20th Annual Iranian Association of Surgeons Congress (IASC), 1999, Tehran, Iran 36. Early detection of breast cancer The 10th Annual Conference of Iran Cancer Institute, 1998, Tehran, Iran 37. Castleman Disease Annual Meeting of the Iranian Hematologists-Oncologists Society, 1998, Tehran, Iran 38. Benign Giant Lymphoma – (Castleman Disease) The 9th Annual Conference of Iran Cancer Institute – Lymphatic System Diseases, 1997, Tehran, Iran 39. Management of Ovarian Cancer Annual Meeting of the Iranian Radiation Oncologist Society, 1995, Tehran, Iran 40. Early Gastric Cancer The 8th Annual Conference of Iran Cancer Institute, 1995, Tehran, Iran 41. Ovarian Stromal Tumors The Ovarian Cancer Congress, 1995, Tehran, Iran 42. Pathology of Glosseal Tumors The 7th Annual Conference of Iran Cancer Institute – Head and Neck Tumors, 1994, Tehran 43. Castleman Disease Iranian Association of Pathologists (IAP), 10th Scientific Sessions (pathology of lymph nodes and bone marrow), 1993, Shiraz, Iran 44. Soft Tissue Tumors The 6th Annual Conference of Iran Cancer Institute, 1993, Tehran, Iran 45. Castleman Disease Iranian Association of Pathologists (IAP), 9th Scientific Sessions, Tehran Iran 46. Cystosarcoma Phyllodes The 1th Annual Conference of Iran Cancer Institute – Breast diseases, 1987, Tehran, Iran Dr. Forouzandeh Fereidooni GRANTS 1. Establishment of Tumor Cell Bank Iran Cancer Institute. Tehran University of Medical Sciences, Tehran, Iran 2. Breast Cancer Photodynamic Therapy Iran Cancer Institute. Tehran University of Medical Sciences, Tehran, Iran 3. Evaluation of Immunohistochemical Patterns to Predict Castleman Disease Progress Iran Cancer Institute. Tehran University of Medical Sciences, Tehran, Iran Dr. Forouzandeh Fereidooni RESEARCH MENTORSHIP 1. Evaluation of Clinicopatholgical and Immunohistochemical Patterns in Castleman Disease; in order to predict the prognosis, 2005, Tehran University of Medical Sciences (Student: Dr. Mojgan Nasiri) 2. Castleman Disease (10 years review of Cancer Institute patients), 2004, Tehran University of Medical Sciences 3. Cartilaginous Tumors (10 year review of Cancer Institute patients), 2003, Tehran University of Medical Sciences (Student Dr. Mehdi Shahrestani) 4. Retroperitoneal Tumor (10 year review of Cancer Institute Patients), 2002, Tehran University of Medical Sciences (Student: Dr. Mohsen Darabi) 5. Skin Appendage Tumor (10 year review of Cancer Institute Patients), 2001, Tehran University of Medical Sciences (Student: Dr. Mohammad Ali Jafari Nedoshen) 6. The histopathologic effect of Plumb on spermatocytic canals, 2001, Shariati Hospital, Tehran, Iran (Student: Dr. Mohammad Yarmohamadi) 7. Appendicitis (5 year review in a general hospital), 2001, Tehran University of Medical Sciences (Student Dr. Firouzeh Hashemi) 8. Metastatic Lymphadenopathies (10 year review of Cancer Institute Patients), 2000, Tehran University of Medical Sciences (Student: Dr. Sasan Moghimi Iraghi) 9. Lip Carcinomas (10 year review of Cancer Institute Patients), 2000, Tehran University of Medical Sciences (Student Dr. Gholam Reza Azimi) 10. Testicular Neoplasms (10 year review of Cancer Institute Patients), 1999, Tehran University of Medical Sciences (Student: Dr. Nima Ostovari) 11. Tongue Neoplasms (10 year review of Cancer Institute Patients), 1999, Tehran University of Medical Sciences (Student: Dr. Vahid Ziadloo) 12. Rectal Tumors (10 years review of Cancer Institute Patients), 1998, Tehran University of Medical Sciences (Student: Dr. Nasrin Motamedi)